Symptomatic Severe Stenosis of Cavernous Internal Carotid Artery Stenting: A Case Report with Short Literature Review

Abstract

Intracranial internal carotid artery (ICA) stenosis is rarely reported as compared with extracranial ICA stenosis. Atherosclerosis is one of the major beginnings of stenosis of vasculatures, which may lead to ischemic stroke causing morbidity and mortality. We report the case of a 60 -year-old man presented to us with complaints of multiple episodes of dizziness, mild headache, and transient left arm weakness for 3 months and had history of smoking, hypercholesterolemia (high level of low-density lipoprotein level = 220 mg/dL), diabetes mellitus, and hypertension under medication. No neurological deficits were observed at the time of admission. Patient underwent angioplasty and stenting with drug-eluting balloon-expandable coronary stent. Patient was discharged well at the 3rd day of procedure. No recurrence of stroke and restenosis were noted till 3 months of follow-up period. Stenting following angioplasty for treatment of symptomatic severe cavernous ICA stenosis with everolimus-eluting coronary balloon-expandable stent, Xience Xpedition, is safe and effective.

Keywords

cavernous internal carotid artery - severe stenosis - angioplasty - everolimus-eluting coronary stent - outcome

Authors' Contributions

M.K. conceived and designed the study, collected data, and wrote and drafted the manuscript. G.R. was responsible for editing and providing technical feedback with the design and analyses.

Ethical Approval

This is a retrospective study, so informed consent was taken from the institute and all involved participants included in this study.

Publikationsverlauf

Artikel online veröffentlicht:
05. November 2024

• References

• 1 Kasner SE, Chimowitz MI, Lynn MJ. et al; Warfarin Aspirin Symptomatic Intracranial Disease Trial Investigators. Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation 2006; 113 (04) 555-563
• 2 Yadav JS, Roubin GS, Iyer S. et al. Elective stenting of the extracranial carotid arteries. Circulation 1997; 95 (02) 376-381
• 3 Sacco RL, Adams R, Albers G. et al; American Heart Association, American Stroke Association Council on Stroke, Council on Cardiovascular Radiology and Intervention, American Academy of Neurology. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke 2006; 37 (02) 577-617
• 4 Miao Z, Jiang L, Wu H. et al. Randomized controlled trial of symptomatic middle cerebral artery stenosis: endovascular versus medical therapy in a Chinese population. Stroke 2012; 43 (12) 3284-3290
• 5 Feldman RL, Trigg L, Gaudier J, Galat J. Use of coronary Palmaz-Schatz stent in the percutaneous treatment of an intracranial carotid artery stenosis. Cathet Cardiovasc Diagn 1996; 38 (03) 316-319
• 6 Al-Mubarak N, Gomez CR, Vitek JJ, Roubin GS. Stenting of symptomatic stenosis of the intracranial internal carotid artery. AJNR Am J Neuroradiol 1998; 19 (10) 1949-1951
• 7 Chimowitz MI, Lynn MJ, Derdeyn CP. et al; SAMMPRIS Trial Investigators. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med 2011; 365 (11) 993-1003
• 8 Mukherjee D, Patil CG. Epidemiology and the global burden of stroke. World Neurosurg 2011; 76 (06) S85-S90
• 9 Banerjee C, Chimowitz MI. Stroke caused by atherosclerosis of the major intracranial arteries. Circ Res 2017; 120 (03) 502-513
• 10 Barrett KM, Brott TG. Stroke caused by extracranial disease. Circ Res 2017; 120 (03) 496-501
• 11 Fiorella D, Levy EI, Turk AS. et al. US multicenter experience with the wingspan stent system for the treatment of intracranial atheromatous disease: periprocedural results. Stroke 2007; 38 (03) 881-887
• 12 Gupta R, Schumacher HC, Mangla S. et al. Urgent endovascular revascularization for symptomatic intracranial atherosclerotic stenosis. Neurology 2003; 61 (12) 1729-1735
• 13 Gröschel K, Schnaudigel S, Pilgram SM, Wasser K, Kastrup A. A systematic review on outcome after stenting for intracranial atherosclerosis. Stroke 2009; 40 (05) e340-e347
• 14 Marks MP, Wojak JC, Al-Ali F. et al. Angioplasty for symptomatic intracranial stenosis: clinical outcome. Stroke 2006; 37 (04) 1016-1020
• 15 Bangalore S, Kumar S, Fusaro M. et al. Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials. Circulation 2012; 125 (23) 2873-2891
• 16 Ma L, Wang F, Feng H. et al. Endovascular treatment of symptomatic severe intracranial atherosclerotic stenosis with a novel intracranial dedicated drug-eluting stent: a more effective treatment approach. Front Neurol 2024; 15: 1304524
• 17 SSYLVIA Study Investigators. Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial Arteries (SSYLVIA): study results. Stroke 2004; 35 (06) 1388-1392
• 18 Bose A, Hartmann M, Henkes H. et al. A novel, self-expanding, nitinol stent in medically refractory intracranial atherosclerotic stenoses: the Wingspan study. Stroke 2007; 38 (05) 1531-1537
• 19 Narwal P, Cutting S, Prabhakaran S, Yaghi S. Diagnosis and management of active intracranial atherosclerotic disease: a case study. Stroke 2018; 49 (06) e221-e223